









Markets
/
Stocks
/
nasdaq-tlsa
/

Tiziana Life Sciences Ltd

TLSA

View Detailed Chart

2.380USD

-0.120-4.80%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

265.28MMarket Cap

--P/E TTM



Tiziana Life Sciences Ltd

2.380

-0.120-4.80%

Overview Company Financials

Financials

Intraday

30m

Today

-4.80%

5 Days

+27.96%

1 Month

+57.62%

6 Months

+250.88%

Year to Date

+241.86%

1 Year

+135.78%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

BUY

Current Rating

8.000

Target Price

236.13%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Tiziana Life Sciences Ltd

TLSA

Apple Inc

AAPL

Lyft Inc

LYFT

GE Vernova Inc

GEV

UnitedHealth Group Inc

UNH

Cigna Group

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(1)

Buy(9)

Indicators

Sell(2)

Neutral(1)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.181

Buy

RSI(14)

77.074

Buy

STOCH(KDJ)(9,3,3)

86.379

Neutral

ATR(14)

0.194

High Vlolatility

CCI(14)

136.035

Buy

Williams %R

18.803

Overbought

TRIX(12,20)

1.435

Sell

StochRSI(14)

26.446

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

2.232

Buy

MA10

1.978

Buy

MA20

1.739

Buy

MA50

1.598

Buy

MA100

1.418

Buy

MA200

1.158

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company that is specialized in the developing transformative therapies for neurodegenerative and neuroinflammatory. The Company’s clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Alzheimer’s, and ALS. Its lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s and other CNS indications. Its Anti IL-6R mAb (TZLS-501), a fully human mAb binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune disease and cancer, reducing circulating levels of the IL-6 cytokine.

Ticker SymbolTLSA

CompanyTiziana Life Sciences Ltd

CEOMr. Ivor Elrifi

Website